86 filings
Page 4 of 5
8-K
7jryak3z8 a4s035
9 Nov 22
Results of Operations and Financial Condition
4:20pm
8-K
ueiovmj0xnuz94n 6nkw
27 Oct 22
GBS Inc. Initiates Company Name Change to Intelligent Bio Solutions Inc. (INBS) and Announces Key Executive Appointments
11:39am
8-K
bwty ulx6me
11 Oct 22
GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
6:07am
8-K
9nojujnmr xowrj9
29 Sep 22
Departure of Directors or Certain Officers
6:03pm
8-K
7m1rynf3a35sjvle
15 Sep 22
Departure of Directors or Certain Officers
6:15am
8-K
ykqx2n4dohg3h8k2xz
31 Aug 22
Results of Operations and Financial Condition
4:15pm
8-K
1oydd95av q3
21 Jul 22
Amendments to Articles of Incorporation or Bylaws
1:46pm
8-K
2xv7xt sm6
16 Jun 22
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of
5:46pm
8-K
11lbs
11 May 22
GBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights
9:00am
8-K
it0oe 4028p
29 Apr 22
Departure of Directors or Certain Officers
5:00pm
8-K
tdus7qqi118yrfnpk5gc
1 Apr 22
GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center
9:30am
8-K
6sfc3w
24 Mar 22
Departure of Directors or Certain Officers
4:15pm
8-K
2zts aukgz58yn1h
23 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
3sb95eb584wi0xwwysh
28 Feb 22
Departure of Directors or Certain Officers
4:10pm
8-K
evnukvyu208 hoxin
10 Feb 22
GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
4:17pm
8-K
wn7yec
16 Dec 21
GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
4:05pm
8-K
pxoqtznntej1c4vn
1 Dec 21
GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study
4:05pm
8-K
ekkv4t7oo4t88e
24 Nov 21
Life Science Biosensor Diagnostics Pty Ltd Statement in Relation to Recent Sale of Shares in GBS Inc
4:05pm
8-K
ozo67d
17 Nov 21
GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
4:05pm
8-K
npil9a
3 Nov 21
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
5:01pm